drugset / Trial / NCT00524810
Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Evaluation of safety and efficacy of a treatment associating Pegylated Liposomal Doxorubicin + Docetaxel in patients with metastatic breast cancer
Timeline
- Start
- 2004-02
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |
| Subject | Doxorubicin | Other / unclassified | 30 mg/m2 | — |